Ignite Creation Date:
2024-05-06 @ 1:09 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03942094
Status:
UNKNOWN
Last Update Posted:
2022-03-16
First Post:
2019-05-06
Brief Title:
Nilotinib for First-line Newly Diagnosed CML-CP Patients
Sponsor:
Shenzhen Second Peoples Hospital
Organization:
Shenzhen Second Peoples Hospital
Organization Data
Organization:
Shenzhen Second Peoples Hospital
Class:
OTHER
Study ID:
Nilotinib20190426
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shenzhen Second Peoples Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Longgang District Central Hospital of Shenzhen | UNKNOWN |
| Zhongshan Peoples Hospital Guangdong China | OTHER |
| Affiliated Hospital of Guangdong Medical University | OTHER |
| Huazhong University of Science and Technology Union Shenzhen Hospital | UNKNOWN |
| Dongguan Peoples Hospital | OTHER_GOV |